New York, Feb 24, 2026, 08:38 (ET) — Premarket
- Chemours shares were up 0.55% in premarket trading at $18.13.
- Morgan Stanley and Jefferies both raised their price targets to $17, keeping neutral ratings.
- Investors are weighing a soft first-quarter outlook against a push to generate more cash and cut debt.
Chemours shares edged up 0.55% to $18.13 in premarket trade on Tuesday, after closing at $18.03, as fresh analyst target hikes kept attention on a stock still digesting last week’s guidance. (Public)
The move matters because Chemours is heading into the session with Wall Street focused on near-term earnings pressure and leverage, not just the growth story in refrigerants. The company forecast first-quarter adjusted EBITDA — earnings before interest, taxes, depreciation and amortization, excluding certain items — of $120 million to $150 million and said net leverage was about 4.7 times trailing adjusted EBITDA at year-end 2025. (Chemours)
Morgan Stanley lifted its price target to $17 from $15 and kept an Equalweight rating, pointing to higher peer valuation multiples but trimming its EBITDA estimates. The bank said it does not expect “material improvement” in titanium dioxide in 2026 and flagged cash generation as a key test, while also watching for progress on PFAS resolution. (Investing)
Jefferies raised its target to $17 from $14 and maintained a Hold rating, arguing a broader demand recovery could lift EBITDA in the second half of 2026 into 2027. It also said Chemours is likely to lean on free cash flow and asset-sale proceeds to reduce debt. (Investing)
Chemours has tried to reframe the debate around cash and its refrigerants franchise. “Our consolidated fourth quarter results delivered robust cash flow,” Chief Executive Denise Dignam said in the company’s results release, while pointing to the transition toward Opteon refrigerants and a focus on cash generation. (SEC)
The company also put out a separate update late Monday aimed at its semiconductor exposure, saying Gerardo Familiar, president of its Advanced Performance Materials unit, had been appointed to SEMI’s North America advisory board. “Semiconductors are the backbone of modern technology,” Familiar said. (Chemours)
Chemours sells refrigerants under brands including Opteon and Freon, titanium dioxide pigment used in coatings and plastics, and fluoropolymer materials used across industrial and electronics markets, according to Reuters company data. (Reuters)
But the path is messy. A weak housing-linked demand backdrop for titanium dioxide, operational hiccups in materials, and uncertainty around PFAS-related costs could still squeeze cash flow, leaving little margin for error with leverage elevated.
Investors now turn to the open for confirmation that Monday’s bounce can hold, and to near-term calendar markers like the Feb. 27 record date for Chemours’ quarterly dividend, payable March 13. (Chemours)
